Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer statistics, 2022
Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs, et al.
CA A Cancer Journal for Clinicians (2022) Vol. 72, Iss. 1, pp. 7-33
Open Access | Times Cited: 14310

Showing 26-50 of 14310 citing articles:

Cancer incidence estimates for 2022 & projection for 2025: Result from National Cancer Registry Programme, India
Prashant Mathur, Krishnan Sathishkumar, Meesha Chaturvedi, et al.
The Indian Journal of Medical Research (2022) Vol. 156, Iss. 4, pp. 598-598
Open Access | Times Cited: 301
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
Jennifer R. Brown, Barbara Eichhorst, Peter Hillmen, et al.
New England Journal of Medicine (2022) Vol. 388, Iss. 4, pp. 319-332
Open Access | Times Cited: 265
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians
Demetrios Moris, Manisha Palta, Charles Kim, et al.
CA A Cancer Journal for Clinicians (2022) Vol. 73, Iss. 2, pp. 198-222
Open Access | Times Cited: 260
Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer
Mariano Provencio, Ernest Nadal, J.L. González-Larriba, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 6, pp. 504-513
Open Access | Times Cited: 251
Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer
Balázs Győrffy
GeroScience (2023) Vol. 45, Iss. 3, pp. 1889-1898
Open Access | Times Cited: 242
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022
Deborah K. Armstrong, Ronald D. Alvarez, Floor J. Backes, et al.
Journal of the National Comprehensive Cancer Network (2022) Vol. 20, Iss. 9, pp. 972-980
Open Access | Times Cited: 230
Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer
Samantha B. Kemp, Noah Cheng, Nune Markosyan, et al.
Cancer Discovery (2022) Vol. 13, Iss. 2, pp. 298-311
Open Access | Times Cited: 220
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022
Thomas W. Flaig, Philippe E. Spiess, Michael Abern, et al.
Journal of the National Comprehensive Cancer Network (2022) Vol. 20, Iss. 8, pp. 866-878
Open Access | Times Cited: 219
Neoadjuvant therapy for pancreatic cancer
Christoph Springfeld, Cristina R. Ferrone, Matthew H. G. Katz, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 5, pp. 318-337
Closed Access | Times Cited: 194
Advancements in nanoparticle-based treatment approaches for skin cancer therapy
Leli Zeng, B.H. Jaswanth Gowda, Mohammed Gulzar Ahmed, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 191
Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance
Mara H. Sherman, Gregory L. Beatty
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 123-148
Open Access | Times Cited: 189
Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline
W. Kimryn Rathmell, R. Bryan Rumble, Peter J. Van Veldhuizen, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 25, pp. 2957-2995
Open Access | Times Cited: 188
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial
Paula Ghaneh, Daniel H. Palmer, Silvia Cicconi, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 8, Iss. 2, pp. 157-168
Open Access | Times Cited: 179
Translational advances in pancreatic ductal adenocarcinoma therapy
Abdel Hosein, Stephanie K. Dougan, Andrew J. Aguirre, et al.
Nature Cancer (2022) Vol. 3, Iss. 3, pp. 272-286
Open Access | Times Cited: 175
Advances in systemic therapies for triple negative breast cancer
Roberto A. Leon‐Ferre, Matthew P. Goetz
BMJ (2023), pp. e071674-e071674
Open Access | Times Cited: 175
Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer
Ni Wang, Jing‐Yuan Fang
Trends in Microbiology (2022) Vol. 31, Iss. 2, pp. 159-172
Closed Access | Times Cited: 169
Liquid biopsies: the future of cancer early detection
Siobhan Connal, James M. Cameron, Alexandra Sala, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 168
Biology, vulnerabilities and clinical applications of circulating tumour cells
Alexander Ring, Bich Doan Nguyen-Sträuli, Andreas Wicki, et al.
Nature reviews. Cancer (2022) Vol. 23, Iss. 2, pp. 95-111
Open Access | Times Cited: 167
Manganese‐Based Tumor Immunotherapy
Ke Zhang, Chao Qi, Kaiyong Cai
Advanced Materials (2022) Vol. 35, Iss. 19
Closed Access | Times Cited: 158
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2020
Mee Joo Kang, Kyu‐Won Jung, So Hyun Bang, et al.
Cancer Research and Treatment (2023) Vol. 55, Iss. 2, pp. 385-399
Open Access | Times Cited: 155
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions
Zsolt Megyesfalvi, Carl M. Gay, Helmut Popper, et al.
CA A Cancer Journal for Clinicians (2023) Vol. 73, Iss. 6, pp. 620-652
Open Access | Times Cited: 154
Activated fibroblasts in cancer: Perspectives and challenges
Giuseppina Caligiuri, David A. Tuveson
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 434-449
Open Access | Times Cited: 153
Bladder cancer
Lars Dyrskjøt, Donna E. Hansel, Jason A. Efstathiou, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 153
Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications
Xinyang Zhong, Xuefeng He, Yaxian Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 151
Trends in Incidence of Metastatic Prostate Cancer in the US
Mihir Desai, Giovanni Cacciamani, Karanvir Gill, et al.
JAMA Network Open (2022) Vol. 5, Iss. 3, pp. e222246-e222246
Open Access | Times Cited: 150

Scroll to top